These results strongly suggested that NDRG2 inhibited the expression of c-Myc, β-catenin, GLUT1, HK2, PKM2, LDHA, ASCT2, and GLS1 in colorectal cancer. This evidence concerns the gene SLC1A5 and colorectal cancer.